EP0134582A3 - Novel peptides and process for preparing the same and pharmaceutical composition - Google Patents

Novel peptides and process for preparing the same and pharmaceutical composition Download PDF

Info

Publication number
EP0134582A3
EP0134582A3 EP84110619A EP84110619A EP0134582A3 EP 0134582 A3 EP0134582 A3 EP 0134582A3 EP 84110619 A EP84110619 A EP 84110619A EP 84110619 A EP84110619 A EP 84110619A EP 0134582 A3 EP0134582 A3 EP 0134582A3
Authority
EP
European Patent Office
Prior art keywords
same
formula
preparing
pharmaceutical composition
novel peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP84110619A
Other languages
German (de)
French (fr)
Other versions
EP0134582A2 (en
Inventor
Hiroshi Sugano
Ryuichi Ishida
Michio Yamamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of EP0134582A2 publication Critical patent/EP0134582A2/en
Publication of EP0134582A3 publication Critical patent/EP0134582A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

A compound of the formula: wherein A is a group of the formula: R¹ and R² are the same or different and each hydrogen atom, nitro, amino, a protected amino, hydroxy or lower alkoxy,
Y is oxygen atom or a group of the formula: - NR³-,
R³ is hydrogen atom or lower alkyl,
X is methylene or sulphur atom and
the dotted line is an optional double bond,
or a pharmaceutically acceptable acid addition salt thereof is useful as a medicine for the treatment of consciousness disorders. Also processes for the preparation of these compounds are disclosed.
EP84110619A 1983-09-07 1984-09-06 Novel peptides and process for preparing the same and pharmaceutical composition Withdrawn EP0134582A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08323909A GB2146026A (en) 1983-09-07 1983-09-07 Peptides and process for preparing the same
GB8323909 1983-09-07

Publications (2)

Publication Number Publication Date
EP0134582A2 EP0134582A2 (en) 1985-03-20
EP0134582A3 true EP0134582A3 (en) 1986-03-05

Family

ID=10548407

Family Applications (1)

Application Number Title Priority Date Filing Date
EP84110619A Withdrawn EP0134582A3 (en) 1983-09-07 1984-09-06 Novel peptides and process for preparing the same and pharmaceutical composition

Country Status (5)

Country Link
US (1) US4563306A (en)
EP (1) EP0134582A3 (en)
JP (1) JPS6110596A (en)
ES (1) ES8606880A1 (en)
GB (1) GB2146026A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69025272T2 (en) * 1989-11-17 1996-06-27 Takeda Chemical Industries Ltd Therapeutic agent for diseases of the central nervous system
RU2067000C1 (en) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Peptide and a method of its synthesis
JP2002514192A (en) * 1996-11-13 2002-05-14 セフアロン・インコーポレーテツド Cysteine and serine protease inhibitors containing benzothiazo and related heterocyclic groups
GB9708119D0 (en) * 1997-04-22 1997-06-11 Glaxo Group Ltd Chemical compounds
DK1392291T3 (en) 2000-10-30 2007-10-08 Janssen Pharmaceutica Nv Tripeptidyl peptidase inhibitors
US7041681B2 (en) * 2002-04-29 2006-05-09 Janssen Pharmaceutica N.V. Compounds as opioid receptor modulators
ZA200609259B (en) 2004-04-30 2008-07-30 Takeda Pharmaceutical Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303559A1 (en) * 1975-03-08 1976-10-08 Reckitt & Colmann Prod Ltd NEW HISTIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
US4045556A (en) * 1974-10-16 1977-08-30 Eberhard Schwertner Dipeptide derivatives, process for manufacture and pharmaceutical preparations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (en) * 1976-03-23 1984-10-29 武田薬品工業株式会社 peptide
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045556A (en) * 1974-10-16 1977-08-30 Eberhard Schwertner Dipeptide derivatives, process for manufacture and pharmaceutical preparations
FR2303559A1 (en) * 1975-03-08 1976-10-08 Reckitt & Colmann Prod Ltd NEW HISTIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM

Also Published As

Publication number Publication date
GB2146026A (en) 1985-04-11
JPS6110596A (en) 1986-01-18
ES8606880A1 (en) 1986-05-16
EP0134582A2 (en) 1985-03-20
US4563306A (en) 1986-01-07
ES535727A0 (en) 1986-05-16
GB8323909D0 (en) 1983-10-12

Similar Documents

Publication Publication Date Title
EP0283970A3 (en) New peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same
ATE33835T1 (en) COMPOUND WITH ANTIBRONCHOPNEUMOPATHIC ACTIVITY, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
EP0368640A3 (en) Heterocyclic compounds
ES8604565A1 (en) A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same.
ES8801915A1 (en) Piperidine compound.
EP0134582A3 (en) Novel peptides and process for preparing the same and pharmaceutical composition
HUT46536A (en) Process for producing antianxietive pharmaceutical compositions
ATE48001T1 (en) CEPHEM COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL PREPARATIONS.
EP0138344A3 (en) Pyridazinones as beta-adrenoceptor antagonists
EP0383256A3 (en) A novel substituted-acetamide compound and a process for the preparation thereof
ES8504682A1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof.
EP0150505A3 (en) 3-indolecarboxamide compounds
EP0288962A3 (en) Aryl-aralkyl ethers, processes for their preparation and pharmaceutical composition comprising them
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
ES8308833A1 (en) Novel 3-phenyl-1-indanamines, pharmaceutical compositions and methods of preparation.
PT85869A (en) Process for preparing amino acid derivative anti-convulsant
GR3000831T3 (en) Piperazine compounds, process for preparing them, pharmaceutical composition and use
DE3661311D1 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
ES8705463A1 (en) Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them.
EP0081971A3 (en) Novel cephalosporin compound and process for preparing the same
ATE45958T1 (en) PEPTIDES, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION.
EP0214462A3 (en) 3,7-disubstituted-3-cephem compounds and processes for production of the same
EP0316939A3 (en) Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use
EP0189080A3 (en) (1,2,4-oxadiazol-3-yl)-arylmethanones, a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): CH DE FR GB IT LI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): CH DE FR GB IT LI

17P Request for examination filed

Effective date: 19860325

17Q First examination report despatched

Effective date: 19860722

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19861202

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ISHIDA, RYUICHI

Inventor name: YAMAMURA, MICHIO

Inventor name: SUGANO, HIROSHI